, ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death, European Heart Journal | Oxford Academic, vol.2

S. Mendis, P. Puska, and B. Norrving, Global atlas on cardiovascular disease prevention and control. Geneva: World Health Organization in collaboration with the World Heart Federation and the World Stroke Organization, p.155, 2011.

A. J. Moss, W. Zareba, W. J. Hall, H. Klein, D. J. Wilber et al., Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction, N Engl J Med, vol.346, issue.12, pp.877-883, 2002.

G. H. Bardy, K. L. Lee, D. B. Mark, J. E. Poole, D. L. Packer et al., Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure, N Engl J Med, vol.352, issue.3, pp.225-262, 2005.

P. Ponikowski, A. A. Voors, S. D. Anker, H. Bueno, J. Cleland et al., , 2016.

, ESC Guidelines for the diagnosis and treatment of acute and chronic heart failureThe Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC, Eur Heart J, vol.37, issue.27, pp.2129-200, 2016.

A. Mosterd and A. W. Hoes, Clinical epidemiology of heart failure, Heart, 2007.

M. R. Reynolds, D. J. Cohen, A. D. Kugelmass, P. P. Brown, E. R. Becker et al.,

, The Frequency and Incremental Cost of Major Complications Among Medicare Beneficiaries Receiving Implantable Cardioverter-Defibrillators, J Am Coll Cardiol, vol.47, issue.12, pp.2493-2500, 2006.

T. Kleemann, T. Becker, K. Doenges, M. Vater, J. Senges et al., Annual Rate of Transvenous Defibrillation Lead Defects in Implantable Cardioverter-Defibrillators Over a Period of >10 Years. Circulation, vol.115, pp.2474-80, 2007.

C. Borleffs, . Erven-l-van, R. J. Bommel, . Van, . Velde-et-van-der et al., Risk of Failure of Transvenous Implantable Cardioverter-Defibrillator LeadsCLINICAL PERSPECTIVE, Circ Arrhythm Electrophysiol, vol.2, issue.4, pp.411-417, 2009.

P. D. Lambiase, C. Barr, D. Theuns, R. Knops, P. Neuzil et al., Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry, Eur Heart J, vol.35, issue.25, pp.1657-65, 2014.

G. H. Bardy, W. M. Smith, M. A. Hood, I. G. Crozier, I. C. Melton et al., An Entirely Subcutaneous Implantable Cardioverter-Defibrillator, N Engl J Med, vol.363, issue.1, pp.36-44, 2010.

M. K. Essandoh, J. G. Portillo, R. Weiss, A. J. Otey, A. N. Zuleta-alarcon et al., Anesthesia care for subcutaneous implantable cardioverter/defibrillator placement: a single-center experience, J Clin Anesth, vol.31, pp.53-62, 2016.

M. K. Essandoh, A. J. Otey, M. Abdel-rasoul, E. J. Stein, K. R. Turner et al.,

, Monitored Anesthesia Care for Subcutaneous Cardioverter-Defibrillator Implantation: A Single-Center Experience, J Cardiothorac Vasc Anesth, vol.30, issue.5, pp.1228-1261, 2016.

F. Migliore, G. Allocca, V. Calzolari, M. Crosato, D. Facchin et al., Intermuscular Two-Incision Technique for Subcutaneous Implantable Cardioverter Defibrillator Implantation: Results from a Multicenter Registry, Pacing Clin Electrophysiol PACE, vol.40, issue.3, pp.278-85, 2017.

T. F. Brouwer, M. A. Miller, A. Quast, C. Palaniswamy, S. R. Dukkipati et al., Implantation of the Subcutaneous Implantable Cardioverter-Defibrillator, Circ Arrhythm Electrophysiol, vol.10, issue.1, p.4663, 2017.

S. M. Al-khatib, W. G. Stevenson, M. J. Ackerman, W. J. Bryant, D. J. Callans et al., AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society, J Am Coll Cardiol, p.24390, 2017.

R. E. Knops, O. Nordkamp, L. De-groot, J. R. Wilde, and A. , Two-incision technique for implantation of the subcutaneous implantable cardioverter-defibrillator, Heart Rhythm, vol.10, issue.8, pp.1240-1243, 2013.

P. Ferrari, F. Giofrè, D. Filippo, and P. , Intermuscular pocket for subcutaneous implantable cardioverter defibrillator: Single-center experience, J Arrhythmia, vol.32, issue.3, pp.223-229, 2016.

J. Winter, M. Siekiera, D. Shin, C. Meyer, P. Kröpil et al., Intermuscular technique for implantation of the subcutaneous implantable cardioverter defibrillator: longterm performance and complications. Eur Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol, 2016.

B. A. D'souza, A. E. Epstein, F. C. Garcia, Y. Y. Kim, S. C. Agarwal et al., Outcomes in Patients With Congenital Heart Disease Receiving the Subcutaneous Implantable-Cardioverter Defibrillator, JACC Clin Electrophysiol, vol.2, issue.5, pp.615-637, 2016.

T. F. Brouwer, D. Yilmaz, R. Lindeboom, M. S. Buiten, O. Nordkamp et al., Long-Term Clinical Outcomes of Subcutaneous Versus Transvenous Implantable Defibrillator Therapy, J Am Coll Cardiol, vol.68, pp.2047-55, 2016.

R. E. Knops, T. F. Brouwer, C. S. Barr, D. A. Theuns, L. Boersma et al., The learning curve associated with the introduction of the subcutaneous implantable defibrillator, Europace, vol.18, issue.7, pp.1010-1015, 2016.

M. C. Burke, M. R. Gold, B. P. Knight, C. S. Barr, D. Theuns et al.,

, Safety and Efficacy of the Totally Subcutaneous Implantable Defibrillator: 2-Year Results From a Pooled Analysis of the IDE Study and EFFORTLESS Registry, J Am Coll Cardiol, vol.65, issue.16, pp.1605-1620, 2015.

M. R. Gold, J. D. Aasbo, M. F. El-chami, M. Niebauer, J. Herre et al.,

, Subcutaneous implantable cardioverter-defibrillator Post-Approval Study: Clinical characteristics and perioperative results. Heart Rhythm, vol.14, pp.1456-63, 2017.

L. Boersma, C. Barr, R. Knops, D. Theuns, L. Eckardt et al., Implant and Midterm Outcomes of the Subcutaneous Implantable Cardioverter-Defibrillator Registry, J Am Coll Cardiol, vol.70, issue.7, pp.830-871, 2017.

M. Bettin, R. Larbig, B. Rath, A. Fischer, G. Frommeyer et al., Long-Term Experience With the Subcutaneous Implantable Cardioverter-Defibrillator in Teenagers and Young Adults, JACC Clin Electrophysiol, vol.3, issue.13, pp.1499-506, 2017.

T. F. Brouwer, R. E. Knops, V. Kutyifa, C. Barr, B. Mondésert et al., Propensity score matched comparison of subcutaneous and transvenous implantable cardioverter-defibrillator therapy in the SIMPLE and EFFORTLESS studies, Eurospace, vol.0, pp.1-9, 2018.

T. Mela and J. P. Singh, EFFORTLESS S-ICD registry: another step in the right direction, Eur Heart J, vol.35, issue.25, pp.1634-1640, 2014.

V. H. Tan, S. B. Wilton, V. Kuriachan, G. L. Sumner, and D. V. Exner, Impact of Programming Strategies Aimed at Reducing Nonessential Implantable Cardioverter Defibrillator Therapies on Mortality: A Systematic Review and Meta-Analysis, Circ Arrhythm Electrophysiol, vol.7, issue.1, pp.164-70, 2014.

D. H. Birnie, J. S. Healey, G. A. Wells, A. Verma, A. S. Tang et al., Pacemaker or Defibrillator Surgery without Interruption of Anticoagulation, N Engl J Med, vol.368, issue.22, pp.2084-93, 2013.